Skip to main content

Table 2 Characteristics of patients with pressure ulcers after propensity score matching

From: Active topical therapy by “Furuta method” for effective pressure ulcer treatment: a retrospective study

 

d2

D3

D4, 5

DU

 

Compliance group (n = 101)

Non-compliance group (n = 101)

Absolute standardized difference, %

Compliance group (n = 65)

Non-compliance group (n = 65)

Absolute standardized difference, %

Compliance group (n = 38)

Non-compliance group (n = 38)

Absolute standardized difference, %

Compliance group (n = 38)

Non-compliance group (n = 38)

Absolute standardized difference, %

Age (years)

81.9 ± 8.5

82.4 ± 8.2

5.9

82.4 ± 8.6

81.8 ± 10.8

6.1

80.8 ± 12.0

80.3 ± 11.9

4.2

78.2 ± 11.0

77.6 ± 14.3

4.7

Sex (male) (%)

53.4

55.4

4.4

52.3

49.2

4.4

31.6

39.5

9.8

47.4

47.4

0

Hemoglobin (g/dL)

10.7 ± 2.1

10.9 ± 2.0

9.8

10.3 ± 1.9

10.4 ± 1.7

5.5

10.2 ± 2.1

10.3 ± 1.5

5.5

10.1 ± 2.0

10.3 ± 1.8

5.3

Albumin (g/dL)

2.9 ± 0.6

2.9 ± 0.6

0

2.6 ± 0.5

2.6 ± 0.6

0

2.6 ± 0.7

2.6 ± 0.7

0

2.6 ± 0.6

2.6 ± 0.6

9.8

DESIGN-R score at baseline

8.6 ± 4.4

8.2 ± 4.5

8.9

14.7 ± 7.7

15.1 ± 6.5

5.6

25.9 ± 11.4

25.0 ± 9.8

8.5

21.5 ± 8.4

22.1 ± 7.0

7.8

Observational period (day)

23.9 ± 21.1

22.6 ± 21.5

6.1

46.6 ± 53.4

42.1 ± 38.5

9.6

66.3 ± 47.2

63.3 ± 45.8

7.1

49.0 ± 61.5

45.1 ± 42.3

7.4

Locations

            

Sacrum

39

47

 

23

26

-

20

22

-

11

15

-

Coccyx

14

7

-

5

4

-

1

3

-

2

2

-

Greater trochanter

7

8

-

7

4

-

2

1

-

8

4

-

Heel

9

12

-

11

7

-

3

1

-

7

10

-

Ilium

3

6

-

3

5

-

1

2

-

2

2

-

Others

29

21

-

16

19

-

11

9

-

8

5

-